Kensuke Hirasawa Selected Research

Kensuke Hirasawa Research Topics

Disease

14	Neoplasms (Cancer) 12/2020 - 03/2002
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 11/2020
3	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2022 - 01/2022
3	Infections 01/2022 - 03/2010
3	Virus Diseases (Viral Diseases) 07/2009 - 12/2002
2	Breast Neoplasms (Breast Cancer) 01/2014 - 03/2002
2	Carcinoma (Carcinomatosis) 03/2010 - 04/2006
1	Pulmonary Hypertension 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2022
1	ST Elevation Myocardial Infarction 01/2022
1	Ventricular Remodeling 01/2022
1	Right Ventricular Dysfunction 01/2022
1	Thrombosis (Thrombus) 10/2021
1	Stroke (Strokes) 10/2021
1	Myocardial Infarction 10/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Carcinogenesis 02/2015
1	Hypothermia 01/2015
1	Starvation 05/2012
1	Prostatic Neoplasms (Prostate Cancer) 03/2010
1	Vesicular Stomatitis 05/2006
1	Ovarian Epithelial Carcinoma 04/2006
1	Necrosis 08/2004
1	Ovarian Neoplasms (Ovarian Cancer) 03/2002
1	Reoviridae Infections 03/2002

Drug/Important Bio-Agent (IBA)

6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020 - 01/2012
3	Antiviral Agents (Antivirals)IBA 01/2021 - 07/2009
3	protoporphyrin IXIBA 12/2020 - 01/2018
3	Viral ProteinsIBA 03/2010 - 03/2002
2	Heme (Haem)IBA 12/2020 - 01/2018
2	AcidsIBA 10/2019 - 01/2018
2	U 0126 (UO 126)IBA 02/2015 - 01/2012
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2015 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 05/2012 - 04/2006
1	Caspase 3 (Caspase-3)IBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 10/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2020
1	Aminolevulinic Acid (Levulan)FDA Link 12/2020
1	Ferrochelatase (Heme Synthetase)IBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2018
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2016
1	OligonucleotidesIBA 02/2015
1	Small Interfering RNA (siRNA)IBA 02/2015
1	Aligeron (AS 2)IBA 01/2015
1	MHC class II transactivator proteinIBA 01/2014
1	Estrogen ReceptorsIBA 01/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2014
1	HLA-DR Antigens (HLA-DR)IBA 01/2014
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 05/2012
1	Amino Acids FDA Link 05/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2012
1	Peptide Initiation Factors (Initiation Factor)IBA 05/2012
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 05/2012
1	Leucine (L-Leucine)FDA Link 05/2012
1	Double-Stranded RNA (RNA, Double Stranded)IBA 03/2010
1	Biological ProductsIBA 03/2010
1	InterferonsIBA 07/2009
1	Interferon-alpha (Interferon Alfa)IBA 05/2006
1	Antisense OligonucleotidesIBA 04/2006
1	TCF Transcription FactorsIBA 04/2006
1	p38 Mitogen-Activated Protein KinasesIBA 05/2003
1	Phosphotransferases (Kinase)IBA 05/2003
1	Mitogen-Activated Protein Kinase 8IBA 05/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2003
1	AntibodiesIBA 01/2003
1	Methionine (L-Methionine)FDA Link 03/2002

Therapy/Procedure

7	Therapeutics 03/2010 - 03/2002
5	Transcatheter Aortic Valve Replacement 01/2022 - 11/2020
2	Cardiac Resynchronization Therapy 01/2022 - 01/2022
2	Photochemotherapy (Photodynamic Therapy) 12/2020 - 01/2018
2	Injections 03/2010 - 08/2004
1	Contraindications 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Cardiopulmonary Resuscitation (CPR) 01/2022
1	Thrombectomy 10/2021
1	Stents 10/2021
1	Aftercare (After-Treatment) 01/2012